Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Embrace Infant Warmer To Launch In India With Support From GE

This article was originally published in The Gray Sheet

Executive Summary

A 2007 Stanford graduate course in affordable design has paved the way to the upcoming launch of a medical device that could save the lives of 100,000 babies within five years.

You may also be interested in...



Donated MedTech Can Be Poor Fit For Developing Countries, Report Finds

A report published Aug. 1 in The Lancet finds that medical equipment donated by high-income countries to developing nations is often too complex and hard to maintain, and calls instead for more cost-effective and sustainable medical technologies.

Philips Preps NeoPAP Launch To Address Premature Infants’ Developmental Needs

Philips Healthcare’s planned fourth-quarter launch of its NeoPAP neonatal continuous positive airway pressure device for premature infants reinforces the device maker’s philosophy of addressing not just acute episodes of care but also their long-term developmental outcomes.

Philips Preps NeoPAP Launch To Address Premature Infants’ Developmental Needs

Philips Healthcare’s planned fourth-quarter launch of its NeoPAP neonatal continuous positive airway pressure device for premature infants reinforces the device maker’s philosophy of addressing not just acute episodes of care but also their long-term developmental outcomes.

Related Content

Topics

UsernamePublicRestriction

Register

MT029729

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel